APOE genotype affects black-white responses of high-density lipoprotein cholesterol subspecies to aerobic exercise training

Metabolism: Clinical and Experimental

Volumn 57, Issue 12, 2008, Pages 1669-1676

  Obisesan, Thomas O ^a,b,e   Ferrell, Robert E ^c,e   Goldberg, Andrew P ^d,e   Phares, Dana A ^a,e   Ellis, Tina J ^a,e   Hagberg, James M ^a,e  

^a UNIVERSITY OF MARYLAND   (United States)

^b HOWARD UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e Education   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AEROBIC EXERCISE; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; CONTROLLED STUDY; ENDURANCE; ETHNICITY; FEMALE; GENE LOCUS; GENOTYPE; HUMAN; INTRAABDOMINAL FAT; MALE; NUCLEAR MAGNETIC RESONANCE; OXYGEN CONSUMPTION; PARTICLE SIZE; POSTMENOPAUSE; PRIORITY JOURNAL; TRAINING;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; APOLIPOPROTEINS E; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXERCISE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARTICLE SIZE; RISK FACTORS;

EID: 55649124094     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.07.022     Document Type: Article

References (51)

1. Goldbourt U., and Medalie J.H. High density lipoprotein cholesterol and incidence of coronary heart disease-the Israeli Ischemic Heart Disease Study. Am J Epidemiol 109 (1979) 296-308
2. Miller N.E., Thelle D.S., Forde O.H., and Mjos O.D. The Tromso heart study. High-density lipoprotein and coronary heart disease: a prospective case-control study. Lancet 1 (1977) 965-968
3. Stamler J., Daviglus M.L., Garside D.B., Dyer A.R., Greenland P., and Neaton J.D. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 284 (2000) 311-318
4. Watkins L.O., Neaton J.D., and Kuller L.H. Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the Multiple Risk Factor Intervention Trial. Am J Cardiol 57 (1986) 538-545
5. Freedman D.S., Srinivasan S.R., Webber L.S., Burke G.L., and Berenson G.S. Black-white differences in serum lipoproteins during sexual maturation: the Bogalusa Heart Study. J Chronic Dis 40 (1987) 309-318
6. Friday K.E., Srinivasan S.R., Elkasabany A., Dong C., Wattigney W.A., Dalferes Jr. E., et al. Black-white differences in postprandial triglyceride response and postheparin lipoprotein lipase and hepatic triglyceride lipase among young men. Metabolism 48 (1999) 749-754
7. Asztalos B.F., Cupples L.A., Demissie S., Horvath K.V., Cox C.E., Batista M.C., et al. High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 24 (2004) 2181-2187
8. Musliner T.A., and Krauss R.M. Lipoprotein subspecies and risk of coronary disease. Clin Chem 34 (1988) B78-B83
9. Fievet C., and Fruchart J.C. HDL heterogeneity and coronary heart disease. Diabetes Metab Rev 7 (1991) 155-162
10. Rosenson R.S., Otvos J.D., and Freedman D.S. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am J Cardiol 90 (2002) 89-94
11. Mackey R.H., Kuller L.H., Sutton-Tyrrell K., Evans R.W., Holubkov R., and Matthews K.A. Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study. Am J Cardiol 90 (2002) 71i-76i
12. Rice T., Despres J.P., Perusse L., Hong Y., Province M.A., Bergeron J., et al. Familial aggregation of blood lipid response to exercise training in the health, risk factors, exercise training, and genetics (HERITAGE) family study. Circulation 105 (2002) 1904-1908
13. Durstine J.L., and Haskell W.L. Effects of exercise training on plasma lipids and lipoproteins. Exerc Sport Sci Rev 22 (1994) 477-521
14. Williams P.T., Stefanick M.L., Vranizan K.M., and Wood P.D. The effects of weight loss by exercise or by dieting on plasma high-density lipoprotein (HDL) levels in men with low, intermediate, and normal-to-high HDL at baseline. Metabolism 43 (1994) 917-924
15. Halverstadt A., Phares D.A., Wilund K.R., Goldberg A.P., and Hagberg J.M. Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women. Metabolism 56 (2007) 444-450
16. Wilund K.R., Ferrell R.E., Phares D.A., Goldberg A.P., and Hagberg J.M. Changes in high-density lipoprotein-cholesterol subfractions with exercise training may be dependent on cholesteryl ester transfer protein (CETP) genotype. Metabolism 51 (2002) 774-778
17. Kraus W.E., Houmard J.A., Duscha B.D., Knetzger K.J., Wharton M.B., McCartney J.S., et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347 (2002) 1483-1492
18. An P., Borecki I.B., Rankinen T., Despres J.P., Leon A.S., Skinner J.S., et al. Evidence of major genes for plasma HDL, LDL cholesterol and triglyceride levels at baseline and in response to 20 weeks of endurance training: the HERITAGE Family Study. Int J Sports Med 26 (2005) 414-419
19. Mitchell B.D., Kammerer C.M., Blangero J., Mahaney M.C., Rainwater D.L., Dyke B., et al. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation 94 (1996) 2159-2170
20. Leon A.S., Togashi K., Rankinen T., Despres J.P., Rao D.C., Skinner J.S., et al. Association of apolipoprotein E polymorphism with blood lipids and maximal oxygen uptake in the sedentary state and after exercise training in the HERITAGE Family Study. Metabolism 53 (2004) 108-116
21. Zoratti R. A review on ethnic differences in plasma triglycerides and high-density-lipoprotein cholesterol: is the lipid pattern the key factor for the low coronary heart disease rate in people of African origin?. Eur J Epidemiol 14 (1998) 9-21
22. Boekholdt S.M., Souverein O.W., Tanck M.W., Hovingh G.K., Kuivenhoven J.A., Peters R.I., et al. Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels. Clin Genet 69 (2006) 263-270
23. Zimetbaum P., Frishman W.H., Ooi W.L., Derman M.P., Aronson M., Gidez L.I., et al. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study. Arterioscler Thromb 12 (1992) 416-423
24. Lewis G.F., and Rader D.J. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res. 96 (2005) 1221-1232
25. Brewer Jr. H.B. New features of the National Cholesterol Education Program Adult Treatment Panel III lipid-lowering guidelines. Clin Cardiol 26 (2003) III19-III24
26. Dietary guidelines for healthy American adults. A statement for physicians and health professionals by the Nutrition Committee, American Heart Association. Circulation 77 (1988) 721A-724A
27. Warnick G.R., Nguyen T., Bergelin R.O., Wahl P.W., and Albers J.J. Lipoprotein quantification: an electrophoretic method compared with the Lipid Research Clinics method. Clin Chem 28 (1982) 2116-2120
28. Gidez L.I., Miller G.J., Burstein M., Slagle S., and Eder H.A. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 23 (1982) 1206-1223
29. Otvos J.D., Jeyarajah E.J., and Bennett D.W. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. Clin Chem 37 (1991) 377-386
30. Otvos J.D., Jeyarajah E.J., and Cromwell W.C. Measurement issues related to lipoprotein heterogeneity. Am J Cardiol 90 (2002) 22i-29i
31. Otvos J.D., Jeyarajah E.J., Bennett D.W., and Krauss R.M. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 38 (1992) 1632-1638
32. Nicklas B.J., Rogus E.M., Colman E.G., and Goldberg A.P. Visceral adiposity, increased adipocyte lipolysis, and metabolic dysfunction in obese postmenopausal women. Am J Physiol 270 (1996) E72-E78
33. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
34. Hagberg J.M., Ferrell R.E., Katzel L.I., Dengel D.R., Sorkin J.D., and Goldberg A.P. Apolipoprotein E genotype and exercise training-induced increases in plasma high-density lipoprotein (HDL)- and HDL2-cholesterol levels in overweight men. Metabolism 48 (1999) 943-945
35. Obisesan T.O., Leeuwenburgh C., Phillips T., Ferrell R.E., Phares D.A., Prior S.J., et al. C-reactive protein genotypes affect baseline, but not exercise training-induced changes, in C-reactive protein levels. Arterioscler Thromb Vasc Biol 24 (2004) 1874-1879
36. Dallongeville J., Lussier-Cacan S., and Davignon J. Modulation of plasma triglyceride levels by APOE phenotype: a meta-analysis. J Lipid Res 33 (1992) 447-454
37. Fan P., and Liu B. Correlation analysis of lipids and apolipoproteins in plasma HDL, LDL and VLDL of normal subjects and endogenous hypertriglyceridemics. Hua Xi Yi Ke Da Xue Xue Bao 26 (1995) 141-145
38. Luc G., Bard J.M., Lussier-Cacan S., Bouthillier D., Parra H.J., Fruchart J.C., et al. High-density lipoprotein particles in octogenarians. Metabolism 40 (1991) 1238-1243
39. Cheung M.C., Brown B.G., Wolf A.C., and Albers J.J. Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J Lipid Res 32 (1991) 383-394
40. Johansson J., Carlson L.A., Landou C., and Hamsten A. High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 11 (1991) 174-182
41. Cheung M.C., Segrest J.P., Albers J.J., Cone J.T., Brouillette C.G., Chung B.H., et al. Characterization of high density lipoprotein subspecies: structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography. J Lipid Res 28 (1987) 913-929
42. Miller N.E. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 113 (1987) 589-597
43. Sepehrnia B., Kamboh M.I., Adams-Campbell L.L., Bunker C.H., Nwankwo M., Majumder P.P., et al. Genetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks. Am J Hum Genet 45 (1989) 586-591
44. Heller D.A., de Faire U., Pedersen N.L., Dahlen G., and McClearn G.E. Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 328 (1993) 1150-1156
45. Kamboh M.I., Aston C.E., Ferrell R.E., and Hamman R.F. Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites. Atherosclerosis 98 (1993) 201-211
46. Hayden K.M., Zandi P.P., Lyketsos C.G., Tschanz J.T., Norton M.C., Khachaturian A.S., et al. Apolipoprotein E genotype and mortality: findings from the Cache County Study. J Am Geriatr Soc 53 (2005) 935-942
47. Herbert P.N., Bernier D.N., Cullinane E.M., Edelstein L., Kantor M.A., and Thompson P.D. High-density lipoprotein metabolism in runners and sedentary men. JAMA 252 (1984) 1034-1037
48. Srinivasan S.R., Ehnholm C., Wattigney W., and Berenson G.S. Apolipoprotein E polymorphism and its association with serum lipoprotein concentrations in black versus white children: the Bogalusa Heart Study. Metabolism 42 (1993) 381-386
49. Hixson J.E. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb 11 (1991) 1237-1244
50. Anuurad E., Rubin J., Lu G., Pearson T.A., Holleran S., Ramakrishnan R., et al. Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol. J Lipid Res 47 (2006) 2475-2481
51. Wood P.D., and Haskell W.L. The effect of exercise on plasma high density lipoproteins. Lipids 14 (1979) 417-427